Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 24 | 2017 | 871 | 3.910 |
Why?
|
Adrenergic beta-Antagonists | 23 | 2020 | 323 | 3.890 |
Why?
|
Receptors, Adrenergic, beta-2 | 16 | 2018 | 123 | 2.720 |
Why?
|
Nadolol | 12 | 2020 | 38 | 2.290 |
Why?
|
Adrenergic beta-Agonists | 11 | 2020 | 137 | 1.710 |
Why?
|
Propanolamines | 10 | 2017 | 44 | 1.410 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 9 | 2016 | 106 | 1.380 |
Why?
|
Receptors, Adrenergic, beta | 10 | 2020 | 97 | 1.060 |
Why?
|
Adrenergic beta-2 Receptor Antagonists | 7 | 2020 | 19 | 0.950 |
Why?
|
Propranolol | 6 | 2020 | 156 | 0.780 |
Why?
|
Receptors, G-Protein-Coupled | 6 | 2022 | 488 | 0.770 |
Why?
|
Carbazoles | 4 | 2017 | 87 | 0.710 |
Why?
|
Eosinophils | 2 | 2017 | 162 | 0.700 |
Why?
|
Receptors, Adrenergic | 6 | 2020 | 46 | 0.660 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 2016 | 6 | 0.580 |
Why?
|
Drug Discovery | 2 | 2022 | 324 | 0.580 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2016 | 24 | 0.570 |
Why?
|
Anti-Asthmatic Agents | 4 | 2015 | 118 | 0.550 |
Why?
|
Epithelial Cells | 3 | 2017 | 1818 | 0.500 |
Why?
|
Inflammation | 6 | 2017 | 2522 | 0.440 |
Why?
|
Ligands | 11 | 2014 | 995 | 0.430 |
Why?
|
Mucins | 3 | 2015 | 285 | 0.410 |
Why?
|
Mice, Inbred BALB C | 7 | 2017 | 2314 | 0.400 |
Why?
|
Albuterol | 2 | 2015 | 76 | 0.400 |
Why?
|
Lung | 4 | 2017 | 3151 | 0.400 |
Why?
|
Exercise | 4 | 2020 | 1183 | 0.400 |
Why?
|
Animals | 54 | 2020 | 59536 | 0.390 |
Why?
|
Signal Transduction | 15 | 2020 | 11965 | 0.390 |
Why?
|
Disease Models, Animal | 7 | 2017 | 7222 | 0.380 |
Why?
|
Ovalbumin | 5 | 2017 | 254 | 0.350 |
Why?
|
Epinephrine | 4 | 2020 | 255 | 0.340 |
Why?
|
Myocardium | 9 | 2003 | 1313 | 0.320 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 461 | 0.320 |
Why?
|
Glucocorticoids | 1 | 2011 | 629 | 0.310 |
Why?
|
Bronchodilator Agents | 1 | 2010 | 219 | 0.310 |
Why?
|
Metoprolol | 1 | 2007 | 28 | 0.300 |
Why?
|
Myocardial Contraction | 5 | 2003 | 291 | 0.290 |
Why?
|
Dexamethasone | 1 | 2011 | 1450 | 0.280 |
Why?
|
Interleukin-13 | 2 | 2017 | 135 | 0.280 |
Why?
|
Drug Information Services | 1 | 2005 | 11 | 0.270 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2005 | 42 | 0.270 |
Why?
|
Bronchi | 2 | 2017 | 326 | 0.250 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 2 | 2020 | 17 | 0.250 |
Why?
|
Adrenergic alpha-Antagonists | 4 | 1988 | 67 | 0.250 |
Why?
|
GTP-Binding Proteins | 5 | 1999 | 321 | 0.240 |
Why?
|
Receptors, Cell Surface | 2 | 1998 | 862 | 0.240 |
Why?
|
Mice | 23 | 2017 | 34495 | 0.240 |
Why?
|
Respiratory Hypersensitivity | 2 | 2017 | 51 | 0.240 |
Why?
|
Alprenolol | 5 | 2015 | 12 | 0.240 |
Why?
|
Bronchial Hyperreactivity | 2 | 2016 | 53 | 0.230 |
Why?
|
Mice, Transgenic | 13 | 2017 | 4143 | 0.230 |
Why?
|
Phenotype | 8 | 2020 | 6295 | 0.210 |
Why?
|
Spectrometry, Fluorescence | 1 | 2022 | 209 | 0.200 |
Why?
|
Coronary Vessels | 3 | 2003 | 665 | 0.200 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2007 | 1265 | 0.200 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2015 | 254 | 0.200 |
Why?
|
Models, Biological | 3 | 2015 | 3254 | 0.190 |
Why?
|
Receptors, Serotonin | 3 | 1989 | 46 | 0.190 |
Why?
|
Mice, Inbred C57BL | 6 | 2017 | 6942 | 0.190 |
Why?
|
Muscle, Smooth | 5 | 2014 | 236 | 0.180 |
Why?
|
Norepinephrine | 5 | 1993 | 272 | 0.180 |
Why?
|
Graft vs Tumor Effect | 1 | 2020 | 139 | 0.180 |
Why?
|
Methacholine Chloride | 3 | 2009 | 29 | 0.180 |
Why?
|
Protein Transport | 1 | 2022 | 734 | 0.180 |
Why?
|
Isoproterenol | 7 | 1999 | 127 | 0.170 |
Why?
|
Formoterol Fumarate | 2 | 2016 | 51 | 0.170 |
Why?
|
Drug Inverse Agonism | 2 | 2010 | 6 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2011 | 4938 | 0.170 |
Why?
|
Ethanolamines | 3 | 2013 | 34 | 0.170 |
Why?
|
Viruses | 1 | 2020 | 159 | 0.170 |
Why?
|
Pharmacology | 1 | 1998 | 11 | 0.170 |
Why?
|
Cell Culture Techniques | 2 | 2020 | 598 | 0.170 |
Why?
|
Coronary Disease | 1 | 2003 | 764 | 0.170 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 2315 | 0.160 |
Why?
|
Databases, Factual | 1 | 2005 | 2218 | 0.160 |
Why?
|
Adrenergic alpha-Agonists | 2 | 1988 | 42 | 0.160 |
Why?
|
Neuroprotective Agents | 1 | 2020 | 215 | 0.160 |
Why?
|
Male | 28 | 2020 | 123000 | 0.160 |
Why?
|
Respiratory Function Tests | 2 | 2010 | 318 | 0.160 |
Why?
|
Pyroglyphidae | 1 | 2017 | 12 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2017 | 259 | 0.150 |
Why?
|
Arrestins | 2 | 2015 | 46 | 0.150 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2020 | 406 | 0.150 |
Why?
|
Humans | 36 | 2022 | 261506 | 0.150 |
Why?
|
T-Lymphocytes | 2 | 2020 | 3869 | 0.150 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2017 | 280 | 0.150 |
Why?
|
Xanthines | 2 | 2013 | 29 | 0.140 |
Why?
|
Mucus | 1 | 2016 | 119 | 0.140 |
Why?
|
Cyclopropanes | 1 | 2016 | 88 | 0.140 |
Why?
|
Metaplasia | 1 | 2017 | 383 | 0.140 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 4 | 2015 | 234 | 0.140 |
Why?
|
Peptidomimetics | 1 | 2015 | 26 | 0.140 |
Why?
|
Repressor Proteins | 2 | 2014 | 1664 | 0.140 |
Why?
|
Aspergillosis, Allergic Bronchopulmonary | 1 | 2015 | 34 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2015 | 67 | 0.130 |
Why?
|
Mucin 5AC | 1 | 2015 | 75 | 0.130 |
Why?
|
Bisoprolol | 3 | 2020 | 11 | 0.130 |
Why?
|
Aminopyridines | 1 | 2016 | 212 | 0.120 |
Why?
|
Editorial Policies | 1 | 2015 | 87 | 0.120 |
Why?
|
Monocytes | 1 | 2018 | 788 | 0.120 |
Why?
|
Research Report | 1 | 2015 | 144 | 0.120 |
Why?
|
Airway Resistance | 3 | 2014 | 42 | 0.120 |
Why?
|
Nuclear Receptor Coactivator 3 | 2 | 2014 | 383 | 0.120 |
Why?
|
Drug Design | 2 | 2007 | 375 | 0.120 |
Why?
|
Adenosine A1 Receptor Antagonists | 1 | 2013 | 5 | 0.120 |
Why?
|
Muscle Contraction | 6 | 2014 | 218 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 904 | 0.110 |
Why?
|
Antiviral Agents | 1 | 2020 | 1230 | 0.110 |
Why?
|
Memory, Long-Term | 1 | 2013 | 39 | 0.110 |
Why?
|
Mice, Knockout | 4 | 2016 | 5710 | 0.110 |
Why?
|
Stress, Psychological | 1 | 2020 | 1000 | 0.110 |
Why?
|
Nuclear Proteins | 2 | 2014 | 3343 | 0.110 |
Why?
|
Guinea Pigs | 6 | 1992 | 241 | 0.110 |
Why?
|
Receptors, Androgen | 2 | 2014 | 878 | 0.100 |
Why?
|
Ileum | 6 | 1992 | 165 | 0.100 |
Why?
|
Bronchoconstrictor Agents | 2 | 2009 | 16 | 0.100 |
Why?
|
Kidney | 3 | 1989 | 2146 | 0.100 |
Why?
|
Pneumonia | 1 | 2017 | 751 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 1 | 2017 | 1242 | 0.100 |
Why?
|
Membrane Proteins | 1 | 2022 | 2819 | 0.100 |
Why?
|
In Vitro Techniques | 8 | 1993 | 1618 | 0.100 |
Why?
|
Thiophenes | 1 | 1992 | 148 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 1586 | 0.100 |
Why?
|
Benzamides | 1 | 2016 | 1832 | 0.100 |
Why?
|
Periodicals as Topic | 1 | 2015 | 338 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 1064 | 0.090 |
Why?
|
Memory Disorders | 1 | 2013 | 295 | 0.090 |
Why?
|
Phosphorylation | 2 | 2017 | 4804 | 0.090 |
Why?
|
Respiratory Mucosa | 1 | 2011 | 206 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2011 | 684 | 0.090 |
Why?
|
Bronchoconstriction | 2 | 2015 | 22 | 0.090 |
Why?
|
Serotonin Antagonists | 2 | 1989 | 41 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1763 | 0.090 |
Why?
|
Female | 16 | 2020 | 141928 | 0.090 |
Why?
|
Catecholamines | 2 | 2020 | 101 | 0.090 |
Why?
|
Cardiomegaly | 2 | 2003 | 195 | 0.080 |
Why?
|
Myocytes, Cardiac | 3 | 2020 | 764 | 0.080 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2007 | 93 | 0.080 |
Why?
|
Infusion Pumps | 1 | 2007 | 61 | 0.080 |
Why?
|
Injections, Intraperitoneal | 1 | 2007 | 197 | 0.080 |
Why?
|
Bronchial Provocation Tests | 1 | 2007 | 18 | 0.080 |
Why?
|
Research Design | 1 | 2015 | 1544 | 0.080 |
Why?
|
Cytokines | 2 | 2020 | 2809 | 0.080 |
Why?
|
HEK293 Cells | 3 | 2022 | 1489 | 0.080 |
Why?
|
Serotonin | 4 | 1995 | 264 | 0.070 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 5767 | 0.070 |
Why?
|
Electric Stimulation | 5 | 1993 | 426 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2014 | 3154 | 0.070 |
Why?
|
Heart | 4 | 1997 | 1223 | 0.070 |
Why?
|
Quinoxalines | 1 | 1986 | 95 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 4053 | 0.070 |
Why?
|
Alzheimer Disease | 1 | 2013 | 855 | 0.070 |
Why?
|
Rats | 6 | 2020 | 6086 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 1062 | 0.060 |
Why?
|
Endothelium, Vascular | 3 | 1995 | 891 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2020 | 6550 | 0.060 |
Why?
|
Heart Failure | 4 | 2007 | 2516 | 0.060 |
Why?
|
beta-Adrenergic Receptor Kinases | 3 | 1999 | 58 | 0.060 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 1688 | 0.060 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2003 | 37 | 0.060 |
Why?
|
Administration, Oral | 1 | 2007 | 1544 | 0.060 |
Why?
|
Histamine Antagonists | 2 | 1997 | 17 | 0.060 |
Why?
|
Indoles | 1 | 1989 | 1009 | 0.060 |
Why?
|
Mutation | 6 | 2014 | 15179 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2003 | 81 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2020 | 7226 | 0.060 |
Why?
|
Renin-Angiotensin System | 1 | 2003 | 103 | 0.050 |
Why?
|
Adult | 6 | 2020 | 77950 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2006 | 584 | 0.050 |
Why?
|
Ventricular Function, Left | 3 | 1997 | 603 | 0.050 |
Why?
|
Antibodies | 1 | 2006 | 838 | 0.050 |
Why?
|
Cyclic AMP | 2 | 2015 | 358 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2018 | 2588 | 0.050 |
Why?
|
Autoantibodies | 1 | 2006 | 576 | 0.050 |
Why?
|
Heart Rate | 3 | 2020 | 737 | 0.050 |
Why?
|
Respiratory Mechanics | 1 | 2003 | 173 | 0.050 |
Why?
|
Virus Internalization | 1 | 2022 | 88 | 0.050 |
Why?
|
Prostaglandin D2 | 1 | 2001 | 26 | 0.050 |
Why?
|
Nanotechnology | 1 | 2022 | 137 | 0.050 |
Why?
|
Methiothepin | 2 | 1992 | 2 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 3472 | 0.050 |
Why?
|
Blotting, Western | 1 | 2007 | 3536 | 0.050 |
Why?
|
Macrophages, Peritoneal | 1 | 2001 | 66 | 0.050 |
Why?
|
Blood Pressure | 4 | 2020 | 1467 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2013 | 32848 | 0.050 |
Why?
|
Up-Regulation | 2 | 1997 | 2450 | 0.050 |
Why?
|
Epoprostenol | 1 | 2001 | 75 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2001 | 148 | 0.050 |
Why?
|
Luciferases | 1 | 2022 | 445 | 0.050 |
Why?
|
Pressoreceptors | 1 | 2000 | 18 | 0.050 |
Why?
|
Canada | 1 | 2021 | 429 | 0.050 |
Why?
|
Rats, Inbred Strains | 3 | 1989 | 410 | 0.050 |
Why?
|
I-kappa B Proteins | 1 | 2001 | 170 | 0.050 |
Why?
|
Pilot Projects | 1 | 2007 | 2803 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2003 | 1538 | 0.050 |
Why?
|
Reflex | 1 | 2000 | 68 | 0.050 |
Why?
|
Immunoblotting | 2 | 2013 | 886 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2001 | 148 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 1450 | 0.050 |
Why?
|
Adrenergic Agents | 1 | 2020 | 18 | 0.050 |
Why?
|
Electric Conductivity | 1 | 2020 | 94 | 0.050 |
Why?
|
Bioreactors | 1 | 2020 | 49 | 0.050 |
Why?
|
Rats, Long-Evans | 1 | 2020 | 101 | 0.050 |
Why?
|
Sulfonamides | 1 | 1989 | 1823 | 0.050 |
Why?
|
G-Protein-Coupled Receptor Kinase 3 | 1 | 1999 | 14 | 0.040 |
Why?
|
Maze Learning | 1 | 2020 | 132 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 166 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2022 | 769 | 0.040 |
Why?
|
Receptors, Nicotinic | 1 | 2000 | 190 | 0.040 |
Why?
|
Species Specificity | 1 | 2020 | 777 | 0.040 |
Why?
|
Adipogenesis | 1 | 2020 | 105 | 0.040 |
Why?
|
Hydrocortisone | 1 | 2020 | 388 | 0.040 |
Why?
|
Tissue Scaffolds | 1 | 2020 | 135 | 0.040 |
Why?
|
Lactic Acid | 1 | 2020 | 305 | 0.040 |
Why?
|
Random Allocation | 1 | 2020 | 703 | 0.040 |
Why?
|
Histamine Agonists | 1 | 1997 | 2 | 0.040 |
Why?
|
Receptors, Histamine H2 | 1 | 1997 | 12 | 0.040 |
Why?
|
Kinetics | 2 | 2020 | 2049 | 0.040 |
Why?
|
Peripheral Blood Stem Cells | 1 | 2017 | 9 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2018 | 187 | 0.040 |
Why?
|
Receptor Aggregation | 1 | 1997 | 14 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2020 | 675 | 0.040 |
Why?
|
Adenylyl Cyclases | 2 | 1995 | 87 | 0.040 |
Why?
|
CHO Cells | 1 | 1997 | 311 | 0.040 |
Why?
|
Precipitin Tests | 1 | 1997 | 329 | 0.040 |
Why?
|
Binding, Competitive | 1 | 1997 | 300 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2020 | 269 | 0.040 |
Why?
|
Protein Conformation | 2 | 1997 | 1258 | 0.040 |
Why?
|
Reserpine | 2 | 1987 | 10 | 0.040 |
Why?
|
Hypoxia | 1 | 2020 | 443 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2018 | 460 | 0.040 |
Why?
|
Cystamine | 2 | 1986 | 6 | 0.040 |
Why?
|
Cricetinae | 1 | 1997 | 706 | 0.040 |
Why?
|
Pharmaceutical Preparations | 1 | 1998 | 152 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 591 | 0.040 |
Why?
|
Clonidine | 2 | 1986 | 71 | 0.040 |
Why?
|
Transcription Factors | 2 | 2020 | 5270 | 0.030 |
Why?
|
Salmeterol Xinafoate | 1 | 2015 | 22 | 0.030 |
Why?
|
Fetal Heart | 1 | 1996 | 105 | 0.030 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2017 | 266 | 0.030 |
Why?
|
beta-Arrestins | 1 | 2015 | 44 | 0.030 |
Why?
|
Aspergillus niger | 1 | 2015 | 25 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2017 | 593 | 0.030 |
Why?
|
Polymers | 1 | 1997 | 223 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 7789 | 0.030 |
Why?
|
Pindolol | 1 | 1995 | 10 | 0.030 |
Why?
|
Fish Oils | 1 | 1995 | 88 | 0.030 |
Why?
|
Muscle Relaxation | 2 | 1993 | 19 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 2063 | 0.030 |
Why?
|
Peer Review, Research | 1 | 2015 | 66 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 1994 | 39 | 0.030 |
Why?
|
Cell Count | 1 | 2015 | 508 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 749 | 0.030 |
Why?
|
Peptides | 1 | 2020 | 1479 | 0.030 |
Why?
|
Thiazoles | 2 | 2013 | 726 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 2 | 1993 | 330 | 0.030 |
Why?
|
Cell Membrane | 1 | 1997 | 850 | 0.030 |
Why?
|
Cattle | 1 | 2015 | 783 | 0.030 |
Why?
|
Allergens | 1 | 2015 | 247 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 2843 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 15193 | 0.030 |
Why?
|
Tetrazolium Salts | 1 | 2013 | 54 | 0.030 |
Why?
|
Molsidomine | 1 | 1993 | 1 | 0.030 |
Why?
|
Sydnones | 1 | 1993 | 1 | 0.030 |
Why?
|
Vasoconstriction | 2 | 1993 | 104 | 0.030 |
Why?
|
Gene Expression | 3 | 2015 | 3570 | 0.030 |
Why?
|
Lentivirus | 1 | 2013 | 169 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 568 | 0.030 |
Why?
|
Organ Size | 3 | 2003 | 690 | 0.030 |
Why?
|
Prospective Studies | 1 | 2007 | 12873 | 0.030 |
Why?
|
Middle Aged | 2 | 2010 | 86204 | 0.030 |
Why?
|
Cell Line | 1 | 2020 | 5114 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2013 | 591 | 0.030 |
Why?
|
Benzopyrans | 1 | 1991 | 41 | 0.030 |
Why?
|
Androgens | 1 | 2014 | 511 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 1993 | 219 | 0.020 |
Why?
|
Young Adult | 2 | 2020 | 21445 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 848 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 2195 | 0.020 |
Why?
|
Sympathetic Nervous System | 2 | 1989 | 159 | 0.020 |
Why?
|
Dihydroalprenolol | 1 | 1990 | 2 | 0.020 |
Why?
|
Myosins | 3 | 1995 | 96 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 1993 | 443 | 0.020 |
Why?
|
Adolescent | 1 | 2010 | 31252 | 0.020 |
Why?
|
Sumatriptan | 1 | 1989 | 2 | 0.020 |
Why?
|
Analgesics | 1 | 1993 | 390 | 0.020 |
Why?
|
Metergoline | 1 | 1989 | 2 | 0.020 |
Why?
|
Phenoxybenzamine | 1 | 1989 | 10 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 1989 | 68 | 0.020 |
Why?
|
Body Weight | 3 | 2003 | 1293 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 1217 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2020 | 4078 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 2307 | 0.020 |
Why?
|
United States | 1 | 2005 | 15433 | 0.020 |
Why?
|
Perfusion | 1 | 1989 | 293 | 0.020 |
Why?
|
Membrane Potentials | 3 | 1995 | 424 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2013 | 1694 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2013 | 1152 | 0.020 |
Why?
|
Brimonidine Tartrate | 1 | 1986 | 6 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 3639 | 0.020 |
Why?
|
Nordefrin | 1 | 1986 | 2 | 0.020 |
Why?
|
Idazoxan | 1 | 1986 | 4 | 0.020 |
Why?
|
Dogs | 3 | 1993 | 1155 | 0.020 |
Why?
|
Dioxanes | 1 | 1986 | 11 | 0.020 |
Why?
|
Yohimbine | 1 | 1986 | 26 | 0.020 |
Why?
|
Transfection | 1 | 2011 | 2944 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 2 | 1995 | 68 | 0.020 |
Why?
|
Drug Resistance | 1 | 1986 | 587 | 0.020 |
Why?
|
Fenoterol | 1 | 2003 | 2 | 0.010 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2003 | 16 | 0.010 |
Why?
|
Piperazines | 1 | 1993 | 2101 | 0.010 |
Why?
|
Angiotensinogen | 1 | 2003 | 15 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 2003 | 57 | 0.010 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 40 | 0.010 |
Why?
|
Receptors, Angiotensin | 1 | 2003 | 44 | 0.010 |
Why?
|
Angiotensin I | 1 | 2003 | 18 | 0.010 |
Why?
|
Rats, Inbred WKY | 1 | 2003 | 110 | 0.010 |
Why?
|
Rats, Inbred SHR | 1 | 2003 | 113 | 0.010 |
Why?
|
Losartan | 1 | 2003 | 46 | 0.010 |
Why?
|
Renin | 1 | 2003 | 92 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2330 | 0.010 |
Why?
|
Lung Compliance | 1 | 2003 | 25 | 0.010 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2003 | 80 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2003 | 80 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2003 | 46 | 0.010 |
Why?
|
Dinoprost | 2 | 1993 | 33 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 5159 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 2003 | 151 | 0.010 |
Why?
|
Angiotensin II | 1 | 2003 | 198 | 0.010 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2003 | 151 | 0.010 |
Why?
|
Organ Specificity | 1 | 2003 | 699 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 2001 | 27 | 0.010 |
Why?
|
Ventricular Remodeling | 1 | 2003 | 248 | 0.010 |
Why?
|
Electrophysiology | 2 | 1993 | 333 | 0.010 |
Why?
|
Gene Transfer Techniques | 2 | 1995 | 716 | 0.010 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2001 | 136 | 0.010 |
Why?
|
Cyclopentanes | 1 | 2001 | 40 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2001 | 226 | 0.010 |
Why?
|
alpha7 Nicotinic Acetylcholine Receptor | 1 | 2000 | 57 | 0.010 |
Why?
|
Autonomic Nervous System | 1 | 2000 | 72 | 0.010 |
Why?
|
Collagen | 1 | 2003 | 752 | 0.010 |
Why?
|
Drug Interactions | 2 | 1993 | 553 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2003 | 6150 | 0.010 |
Why?
|
Hemodynamics | 1 | 2003 | 935 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2001 | 558 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 639 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 1819 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 14551 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 1764 | 0.010 |
Why?
|
Atrial Function | 1 | 1997 | 18 | 0.010 |
Why?
|
Isometric Contraction | 1 | 1997 | 18 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2001 | 644 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 1994 | 3101 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2001 | 803 | 0.010 |
Why?
|
Chimera | 1 | 1996 | 145 | 0.010 |
Why?
|
Fetal Death | 1 | 1996 | 113 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1996 | 205 | 0.010 |
Why?
|
Sarcolemma | 1 | 1995 | 32 | 0.010 |
Why?
|
Ventricular Pressure | 1 | 1995 | 46 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1994 | 54 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 1994 | 53 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2003 | 5637 | 0.010 |
Why?
|
Diglycerides | 1 | 1994 | 37 | 0.010 |
Why?
|
Homozygote | 1 | 1996 | 717 | 0.010 |
Why?
|
DNA Primers | 1 | 1996 | 1399 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1995 | 682 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1996 | 613 | 0.010 |
Why?
|
Age Factors | 1 | 2003 | 5377 | 0.010 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1993 | 24 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1994 | 611 | 0.010 |
Why?
|
Exons | 1 | 1996 | 1328 | 0.010 |
Why?
|
Saphenous Vein | 1 | 1993 | 95 | 0.010 |
Why?
|
Reference Values | 1 | 1994 | 1099 | 0.010 |
Why?
|
Nebivolol | 1 | 1991 | 7 | 0.010 |
Why?
|
Point Mutation | 1 | 1994 | 769 | 0.010 |
Why?
|
Swine | 1 | 1995 | 1541 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 3203 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1994 | 846 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 4821 | 0.000 |
Why?
|
Genetic Therapy | 1 | 1994 | 1616 | 0.000 |
Why?
|
Vasoconstrictor Agents | 1 | 1986 | 151 | 0.000 |
Why?
|
Heart Defects, Congenital | 1 | 1996 | 1697 | 0.000 |
Why?
|
Pregnancy | 1 | 1996 | 7573 | 0.000 |
Why?
|